What's New on the FDA Drugs Site
June 22, 2015
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves new antiplatelet drug, Kengreal (cangrelor), used during heart procedure
- FDA Drug Safety Podcast: FDA determines 2013 labeling adequate to manage risk of retinal abnormalities, potential vision loss, and skin discoloration with anti-seizure drug Potiga (ezogabine); requires additional study
- FDA Drug Shortages
- Epinephrine Injection (Updated - Currently in Shortage)
- National Drug Code Directory
- Pediatric Medical, Statistical, and Clinical Pharmacology BPCA Reviews (updated)
- Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations (updated)
.png)
No hay comentarios:
Publicar un comentario